Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0750
-0.0060 (-7.41%)
Oct 27, 2026, 3:59 PM AEDT
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 17.04 million as of October 27, 2026. It is the 40,390th most valuable company in the world and the 1,128th biggest in Australia. Its market cap has decreased by 79.45% in one year.
Market Cap
17.04M
Enterprise Value
-4.75M
Revenue
19.33M
Global Rank
Country Rank
#1,128 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 17.04M, a decrease of -51.85%. That is a compound annual growth rate of -6.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 17.04M | -70.00% |
| Dec 31, 2025 | 56.79M | -60.32% |
| Dec 31, 2024 | 143.10M | 99.47% |
| Dec 29, 2023 | 71.74M | -43.15% |
| Dec 30, 2022 | 126.20M | -50.73% |
| Dec 31, 2021 | 256.15M | -10.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 542.19M |
| Healius | 315.88M |
| Monash IVF Group | 278.59M |
| Identifai Genetics | 92.15M |
| Cryosite | 58.57M |
| BCAL Diagnostics | 27.65M |
| Microba Life Sciences | 25.91M |
| Rhythm Biosciences | 24.06M |